Lifecare AS (LIFE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lifecare AS (LIFE) has a cash flow conversion efficiency ratio of -0.228x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-12.41 Million ≈ $-1.31 Million USD) by net assets (Nkr54.47 Million ≈ $5.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LIFE market cap for the company's overall valuation and market capitalisation.
Lifecare AS - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Lifecare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lifecare AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lifecare AS ranked by their cash flow conversion efficiency. Explore Lifecare AS cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NSN Co. Ltd
KQ:031860
|
-0.143x |
|
Oceanic Beverages Co Inc
TW:1213
|
-0.090x |
|
Park Ha Biological Technology Co., Ltd.
NASDAQ:BYAH
|
N/A |
|
Forgame Holdings Limited
F:FH0
|
0.001x |
|
Herkules S.A.
WAR:HRS
|
0.023x |
|
PN Poong Nyun Co. Ltd
KQ:024940
|
-0.028x |
|
Principal Technologies Inc
V:PTEC
|
4.320x |
|
Burcon NutraScience Corporation
TO:BU
|
0.640x |
Annual Cash Flow Conversion Efficiency for Lifecare AS (2017–2025)
The table below shows the annual cash flow conversion efficiency of Lifecare AS from 2017 to 2025. View LIFE live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr-28.02 Million ≈ $-2.95 Million |
Nkr-110.37 Million ≈ $-11.61 Million |
3.939x | +544.67% |
| 2024-12-31 | Nkr73.98 Million ≈ $7.78 Million |
Nkr-65.54 Million ≈ $-6.90 Million |
-0.886x | -63.52% |
| 2023-12-31 | Nkr66.45 Million ≈ $6.99 Million |
Nkr-36.00 Million ≈ $-3.79 Million |
-0.542x | -67.72% |
| 2022-12-31 | Nkr55.25 Million ≈ $5.81 Million |
Nkr-17.85 Million ≈ $-1.88 Million |
-0.323x | +43.13% |
| 2021-12-31 | Nkr24.25 Million ≈ $2.55 Million |
Nkr-13.77 Million ≈ $-1.45 Million |
-0.568x | -170.03% |
| 2020-12-31 | Nkr13.33 Million ≈ $1.40 Million |
Nkr-2.80 Million ≈ $-294.99K |
-0.210x | +50.64% |
| 2019-12-31 | Nkr15.73 Million ≈ $1.66 Million |
Nkr-6.70 Million ≈ $-705.49K |
-0.426x | -41.36% |
| 2018-12-31 | Nkr22.24 Million ≈ $2.34 Million |
Nkr-6.70 Million ≈ $-705.49K |
-0.301x | -110.57% |
| 2017-12-31 | Nkr-2.35 Million ≈ $-247.41K |
Nkr-6.70 Million ≈ $-705.49K |
2.852x | -- |
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifeca… Read more